The nationwide shortages of Adderall that began in fall 2022 have brought renewed attention to the beleaguered drug, which is used to treat attention-deficit/hyperactivity disorder and narcolepsy.
Adderall became a go-to drug for ADHD over the past two decades but quickly came under fire because of overprescription and misuse. In some cases, people who do not have a proper ADHD diagnosis are using the drug for its perceived cognitive-enhancing effects, leading to an increase in its abuse rates and drug dependence.
